Skip to main content
Uncategorized

Project given the go-ahead to develop new anti-cancer drugs

By 22 de July de 2009November 18th, 2020No Comments
< Back to news
 22.07.2009

Project given the go-ahead to develop new anti-cancer drugs

The Project entitled "Development of new anticancer agents - Bisthiazol", which involves scientists at the Institute for Research in Biomedicine (IRB Barcelona), IDIBELL and the UB, has been approved by the UB's Agency for Assessing and Marketing Research Results (acronym in Catalan AVCRI) in the 2009-2010 second call for applications for project assessment. AVCRI and the Santander Bank, an organisation that funds the programme, have awarded the project 200,000 euros over two years.

For further information